Patent Assignment
Reel/Frame 010364/0755
Change of Name
Recorded: 1999-11-08
Pages: 3
Assignor
PENEDERM, INC.
Executed: 1999-05-19
Assignee
BERTEK PHARMACEUTICALS, INC.
320 LAKESIDE DRIVE, SUITE A, RESEARCH AND DEVELOPMENT DIVISION, FOSTER CITY, CALIFORNIA, 94404
Covered Property
(1)
Use of Vitamin D Analogs to Treat Conditions Related to Increased Oxidative Stress
Patent:
6,262,041 →
Application:
09/287,544 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 17, 1999
From: SERBINOVA, ELENA A.
To: PENEDERM, INC.
Reel/Frame 009971/0286 →
Security Agreement
Oct 24, 2007
From: MYLAN LABORATORIES INC.; DEY, L.P.; DEY, INC.; MYLAN PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 020004/0404 →
Release of Security Interest
Nov 18, 2011
From: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: MYLAN TECHNOLOGIES, INC.; DEY, INC. (F/K/A DEY LABORATORIES, INC.); MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN PHARMACEUTICALS, INC.
Reel/Frame 027261/0928 →
Security Agreement
Nov 21, 2011
From: MYLAN PHARMACEUTICALS, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN TECHNOLOGIES, INC.; MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.)
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 027270/0799 →
Change of Name
Dec 13, 2011
From: BERTEK PHARMACEUTICALS INC.
To: MYLAN BERTEK PHARMACEUTICALS INC.
Reel/Frame 027377/0025 →
Patent Release
Dec 10, 2012
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: DEY PHARMA L.P. (F/K/A DEY, L.P.); MYLAN PHARMACEUTICALS, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN TECHNOLOGIES, INC.
Reel/Frame 029440/0967 →